dr donna h ryan glp-1 H. Ryan, M.D Dr. Eugene H. Ryan, MD
Description
Does the use of glucagon-like peptide-1 (GLP-1) or glucose-dependent insulinotropic polypeptide (GIP) agonists have clinically significant effects on residual gastric volume (RGV) in the periprocedural period
WHY OUR EXPERTLY DESIGNED TEMPLATES ARE A DESIRED MARKETING SOLUTION
Vitamin B6 (as Pyridoxal 5-Phosphate)
Supports normal cell division and methylation processes.*
Summary SGLT2-i exert more consistent BP-lowering effects than GLP-1RA, largely due to their diuretic-like action
Contributes to bone strength and mineralization*2-5,26
